BNGO — BioNano Genomics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for BioNano Genomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	38.4	251	113	66.8	9.47
Net Total Accounts Receivable
Net Total Receivables	2.77	5.32	7.5	9.66	4.77
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	46.8	272	157	140	39.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.91	20.9	29	32.5	24.3
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	60.5	377	308	214	76.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8.95	21.8	35.9	100	37.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	25.4	40	58.1	118	41.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	35.1	337	249	96.2	35.4
Total Liabilities & Shareholders' Equity	60.5	377	308	214	76.7
Total Common Shares Outstanding